scholarly article | Q13442814 |
P819 | ADS bibcode | 2010PLoSO...512960O |
P356 | DOI | 10.1371/JOURNAL.PONE.0012960 |
P932 | PMC publication ID | 2945769 |
P698 | PubMed publication ID | 20930934 |
P5875 | ResearchGate publication ID | 47370937 |
P50 | author | Lorenzo Leoncini | Q56378267 |
Cristiana Bellan | Q56524529 | ||
Anna Onnis | Q38362859 | ||
P2093 | author name string | Giulia De Falco | |
Giuseppina Antonicelli | |||
Monica Onorati | |||
Omar Sherman | |||
Shaheen Sayed | |||
P2860 | cites work | A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. | Q51940347 |
Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss. | Q53380068 | ||
Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. | Q54668860 | ||
Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors | Q59530370 | ||
MYCtranslocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation | Q61641519 | ||
Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation | Q79908853 | ||
"Myc'ed messages": myc induces transcription of E2F1 while inhibiting its translation via a microRNA polycistron | Q21145225 | ||
TarBase: A comprehensive database of experimentally supported animal microRNA targets | Q24537513 | ||
A uniform system for microRNA annotation | Q24540187 | ||
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis | Q24613599 | ||
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
The functions of animal microRNAs | Q27860621 | ||
c-Myc-regulated microRNAs modulate E2F1 expression | Q27861046 | ||
MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
c-MYC: more than just a matter of life and death | Q28205057 | ||
Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer | Q28253941 | ||
Causes and consequences of microRNA dysregulation in cancer | Q28258994 | ||
A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease | Q34480381 | ||
Control of growth and organ size in Drosophila | Q34488131 | ||
Host-virus interaction: a new role for microRNAs | Q34573002 | ||
Myc, cell competition, and compensatory proliferation | Q36215291 | ||
c-myc expression: keep the noise down! | Q36305373 | ||
Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells | Q36327408 | ||
Host-virus genome interactions: macro roles for microRNAs | Q36974986 | ||
Mechanisms of microRNA deregulation in human cancer | Q37249289 | ||
Expression profile of microRNAs in c-Myc induced mouse mammary tumors | Q37439539 | ||
MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors. | Q39769505 | ||
B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression. | Q39837455 | ||
Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a | Q40001339 | ||
Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. | Q41109594 | ||
Molecular diagnosis of Burkitt's lymphoma | Q45207362 | ||
Drosophila myc regulates organ size by inducing cell competition | Q47071644 | ||
dMyc transforms cells into super-competitors | Q47072112 | ||
Rare lymphoid neoplasms coexpressing B- and T-cell antigens. The role of PAX-5 gene methylation in their pathogenesis | Q48003539 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microRNA | Q310899 |
Burkitt lymphoma | Q1016605 | ||
P577 | publication date | 2010-09-24 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma | |
P478 | volume | 5 |
Q35654057 | A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma. |
Q41146867 | An Atypical Presentation of Sporadic Jejunal Burkitt's Lymphoma. |
Q36143915 | Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation |
Q92276416 | Current understanding of the role and regulation of miRNAs in Burkitt lymphoma |
Q38060723 | DNA Methylation of Tumor Suppressive miRNAs in Non-Hodgkin's Lymphomas. |
Q26779821 | EZH2 in normal hematopoiesis and hematological malignancies |
Q37977130 | Epidemiology: clues to the pathogenesis of Burkitt lymphoma |
Q41470046 | HIV-1 Tat induces DNMT over-expression through microRNA dysregulation in HIV-related non Hodgkin lymphomas. |
Q37723512 | Human and Epstein-Barr Virus miRNA Profiling as Predictive Biomarkers for Endemic Burkitt Lymphoma |
Q90012325 | Immunoglobulin heavy variable (IgHV) gene mutation and micro-RNA expression in Burkitt's lymphoma at Moi Teaching and Referral Hospital in Western Kenya |
Q46520241 | Immunohistochemical Profile of MYC Protein in Pediatric Small Round Blue Cell Tumors |
Q44607719 | Integrative microRNA and mRNA deep-sequencing expression profiling in endemic Burkitt lymphoma |
Q34391704 | Lymphomas in sub-Saharan Africa--what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research? |
Q26785379 | MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management |
Q42703031 | Micro-RNA Expression and Function in Lymphomas |
Q30539640 | MicroRNA 9-3p targets β1 integrin to sensitize claudin-low breast cancer cells to MEK inhibition |
Q39580400 | MicroRNA expression in tumor cells from Waldenstrom's macroglobulinemia reflects both their normal and malignant cell counterparts. |
Q35017255 | MicroRNA-9 as a novel prognostic biomarker in human laryngeal squamous cell carcinoma |
Q34314082 | MicroRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor status |
Q57814100 | MicroRNAs as Biomarkers of B-cell Lymphoma |
Q47146703 | Molecular and Cytogenetic Studies in a Child with Burkitt Lymphoma and Ataxia-Telangiectasia Syndrome Harboring MYC Overexpression and Partial Trisomy 8. |
Q37970680 | Molecular profiling of aggressive lymphomas |
Q55510639 | Prognostic significances of overexpression MYC and/or BCL2 in R-CHOP-treated diffuse large B-cell lymphoma: A Systematic review and meta-analysis. |
Q48956040 | Role of immunohistochemistry in the era of genetic testing in MYC-positive aggressive B-cell lymphomas: a study of 209 cases |
Q37626436 | Suppression of microRNA-9 by mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity |
Q37733947 | The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma |
Q34406580 | The alteration of lipid metabolism in Burkitt lymphoma identifies a novel marker: adipophilin |
Q36280547 | The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classification |
Q54323506 | The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes. |
Q26851373 | c-MYC-miRNA circuitry: a central regulator of aggressive B-cell malignancies |
Q34635116 | cMyc/miR-125b-5p signalling determines sensitivity to bortezomib in preclinical model of cutaneous T-cell lymphomas |
Q53618163 | miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma. |
Q21135357 | miRNA expression in colon polyps provides evidence for a multihit model of colon cancer |
Search more.